Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

5-Year Returns for 5 Dow Jones Stocks Entering 2020

Here are five Dow Jones stocks that have done well over the past five years. However, will they power through the market’s volatile environment in 2020, too?

JD.com IPO: 13 Things to Know About a Potential Spin-Off

A JD.com (JD) IPO spinoff may be in the works for the company's logistics business according to a couple of anonymous sources.

Advanced Micro Devices News: AMD Stock Jumps 6% on 2020 Outlook

Advanced Micro Devices (AMD) news for Thursday concerning a positive 2020 outlook for the company has AMD stock heading higher.

Apple Stock Will Keep Climbing

In 2019, Apple stock had its best year of the decade. The momentum of AAPL stock will slow in 2020., but it won't stop.

Purchase Qualcomm Stock Gradually Until Earnings Growth Heats Up

The near-term opportunity in 5G is already priced into Qualcomm stock. This means significant growth traction is likely only in or after 2021.

Why Talks of a Breakup Are Now Coming From Inside Amazon’s House

Amazon's cloud and services businesses appear to be subsidizing its push toward physical infrastructure, and investors don't like it.

Under Armour Stock Appears Balanced Heading Into 2020

Fundamental improvements will push UAA stock higher in 2020, but the magnitude of those gains will be limited by valuation friction.

Regulatory Headwinds Could Disrupt Lyft Stock in 2020

It's tough to see the Lyft stock price making big moves in 2020. As I've said before, if you want to buy a ride-share stock, Uber may be a better opportunity. Otherwise, wait things out until LYFT stock offers a more compelling entry point.

3 Reasons Why GE Stock Could Rally Another 20% in 2020

Despite General Electric’s management team pulling out all the stops for its 2019 recovery efforts, GE stock remains fundamentally undervalued.

Uber, Postmates Challenge California Freelance Law

Uber (UBER) and Postmates are heading to court to try and stop a new California freelance law that could be bad for workers.

Universal Music Deal: Vivendi Sells 10% Stake to Tencent

A Universal Music deal has Vivendi (VIVHY) selling a stake to Tencent (TCEHY) with plans for more deals already in the works.

Seadrill News: SDRL Stock Surges 7% on Contract Extensions

Seadrill (SDRL) news for Tuesday about an extension to some of its contracts in the Middle East have SDRL stock heading higher.

Core Laboratories News: CLB Stock Crumbles 21% on Guidance Cut

Core Laboratories (CLB) news for Tuesday concerning a guidance update for the fourth quarter of 2019 has CLB stock falling hard.

Neovasc News: NVCN Stock Skyrockets 65% on Angina Treatment Application

Neovasc (NVCN) news for Tuesday about the company submitting a PMA to the U.S. Food and Drug Administration has NVCN stock soaring.

There’s No World Where ACB Stock Plummets to Nothing

One analyst recently made a bold prediction that ACB stock is completely worthless. While Aurora remains an extremely risky bet, the stock will never make it to $0.

The Spotify Stock Price Looks Unsustainable in the Near Term

As competition heats up, continuing to hit the right notes in 2020 may prove difficult for SPOT stock

3 Stocks To Trade That Are Ready to Move in 2020

Freeport McMoRan, U.S. Steel and Nio have had very wild trading 2019 -- but these are three tumultuous stocks to trade in 2020.

It’s Probably Best to Lay off Nvidia Stock at These Levels

However, now is not the time to go short Nvidia stock. Investor sentiment is still on its side. Shares could rally higher, proving my "frothy valuation" thesis wrong again. It's tough to see how NVDA could trade at a higher multiple. But its less clear when or if investor sentiment will turn bearish in 2020.

Vascepa’s Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock

Amarin is doubling its sales force for Vascepa, a cholesterol-fighting drug, as potential competitors await results from their own trials.